BALA CYNWYD, Pa., Sept. 19, 2022 (GLOBE NEWSWIRE) — Brodsky & Smith reminds investors of the following research. If you own stock and would like to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. You will not incur any costs or financial obligations.
Gemini Therapeutics, Inc. (Nasdaq-GMTX)
Under the terms of the agreement, Gemini will merge with Disc Medicine, Inc. (“Disc”). Pre-merger Gemini shareholders are expected to own approximately 28% of the combined company and pre-merger Disc shareholders are expected to own approximately 72% of the combined company. The investigation concerns whether Gemini’s board of directors failed in its fiduciary duties to shareholders by failing to conduct due process, including diluting the company’s shareholders in the combined company.
For more information, see https://www.brodskysmith.com/cases/gemini-therapeutics-inc-nasdaq-gmtx/.
CyberOptics Corporation (Nasdaq – CYBE)
Under the terms of the agreement, CyberOptics will be acquired by Nordson Corporation (“Nordson”) (Nasdaq – NDSN). Nordson will acquire CyberOptics for $54.00 per share in cash for each common share outstanding. The investigation concerns whether CyberOptics’ board of directors has failed in its fiduciary duty to shareholders by failing to conduct a fair trial and whether Nordson is underpaying the company.
For more information, see https://www.brodskysmith.com/cases/cyberoptics-corporation-nasdaq-cybe/.
STORE Capital Corporation (NYSE-STOR)
Under the terms of the merger agreement, STORE Capital will be acquired by GIC and Oak Street. STORE Capital shareholders will receive $32.25 in cash for each share of the company they own in a deal valued at approximately $14 billion. The investigation concerns whether the board of STORE Capital has breached its fiduciary duties to shareholders by failing to conduct a fair trial and whether GIC…
